Skip to content

Columbia Ventures Corporation

Creating, Discovering and Enhancing Capital Values

Team
Philosophy
Portfolio
News
Contact

Saladax signs licensing agreement with Janssen for antipsychotic drug testing patents

Read now on BusinessWire.com • June 26, 2018

Like this:

Like Loading...

Author Columbia VenturesPosted on June 26, 2018Categories BIOMEDICAL, Saladax Biomedical

Post navigation

Previous Previous post: New mill to convert wheat straw to pulp expects to hire 80 people

Next Next post: Bethlehem biotech company Saladax signs licensing deal with Johnson & Johnson affiliate

Recent News

2degrees and Lynk Global will bring satellite-to-phone coverage to New Zealand May 18, 2023
Four years after CES, Breadbot’s robotic breadmaker is dishing out loaves at grocery stores May 2, 2023
RealWear unveils next generation assisted reality headset for modern frontline professional with all April 18, 2023

Copyright © Columbia Ventures Corporation. All Rights Reserved.

News by Industry/Company

News by Industry/Company

Search Site

Search for:

Team
Philosophy
Portfolio
News
Contact

Columbia Ventures Corporation

Follow Following
- Columbia Ventures Corporation
- Already have a WordPress.com account? Log in now.

%d bloggers like this: